{"id":"https://openalex.org/A5083254375","orcid":"https://orcid.org/0000-0001-8831-8934","observed_orcids":["https://orcid.org/0000-0001-8831-8934"],"display_name":"Jesse A. Leissa","raw_author_names":["Jesse A Leissa","Jesse A. Leissa","Jesse Leissa","Leissa, Jesse Alton"],"full_name":"Leissa, Jesse Alton","works_count":7,"cited_by_count":75,"summary_stats":{"2yr_mean_citedness":2.0,"h_index":5,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5083254375","orcid":"https://orcid.org/0000-0001-8831-8934","observed_orcids":["https://orcid.org/0000-0001-8831-8934"]},"affiliations":[{"institution":{"id":"https://openalex.org/I1320320070","ror":"https://ror.org/034xvzb47","display_name":"United States Food and Drug Administration","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},"years":[2022]},{"institution":{"id":"https://openalex.org/I1333606569","ror":"https://ror.org/00yf3tm42","display_name":"Center for Drug Evaluation and Research","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},"years":[2022]},{"institution":{"id":"https://openalex.org/I4210150756","ror":"https://ror.org/043cec594","display_name":"AstraZeneca (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]},"years":[2023,2022]},{"institution":{"id":"https://openalex.org/I66946132","ror":"https://ror.org/047s2c258","display_name":"University of Maryland, College Park","country_code":"US","type":"education","lineage":["https://openalex.org/I66946132"]},"years":[2021,2019]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","count":2,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","count":2,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":3.4e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","value":1.97e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","value":1.62e-05,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","value":1.45e-05,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","value":1.24e-05,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.6974131464958191},{"id":"192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","score":0.4289165437221527},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.4234265983104706},{"id":"159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","score":0.30681538581848145},{"id":"127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","score":0.26976537704467773}],"counts_by_year":[{"year":2019,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":5},{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":5},{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":10},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":15},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":23}],"display_name_alternatives":["Jesse A Leissa","Jesse A. Leissa","Jesse Leissa","Leissa, Jesse Alton"],"block_key":"j leissa","works_api_url":"https://api.openalex.org/works?filter=author.id:A5083254375","updated_date":"2026-10-31T12:29:50","created_date":"2019-09-05T00:00:00"}